Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol chemoprevention study in high-risk subjects with colorectal adenomas
2006-001084-27Phase 2Active
- Sponsor
- Ospedali Galliera
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of allopurinol in colorectal cancer (CRC) and colon adenoma (3 arms), sponsored by Ospedali Galliera. Primary endpoint: Change in Ki-67. Started Mar 2007; status: active.
02
Drugs
allopurinol
03
Conditions
colorectal cancer (CRC)colon adenoma
Beyond the preview
Go deeper on 2006-001084-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001084-27.